Trace elements in early phase type 2 diabetes mellitus—A population-based study. The HUNT study in Norway

Journal of Trace Elements in Medicine and Biology

Volumn 40, Issue , 2017, Pages 46-53

  Hansen, Ailin Falkmo ^a   Simić, Anica ^a   Åsvold, Bjørn Olav ^a,b   Romundstad, Pål Richard ^a   Midthjell, Kristian ^a,c   Syversen, Tore ^a   Flaten, Trond Peder ^a  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c Department of Cancer Research and Molecular Medicine   (Norway)

Author keywords

Case control study; HR ICP MS; HUNT3; Trace elements; Type 2 diabetes; Whole blood

Indexed keywords

ARSENIC; BORON; BROMINE; CADMIUM; CALCIUM; CESIUM; CHROMIUM; COPPER; GALLIUM; GOLD; INDIUM; IRON; LEAD; MAGNESIUM; MANGANESE; MERCURY; MOLYBDENUM; NICKEL; RUBIDIUM; SELENIUM; SILVER; STRONTIUM; TANTALUM; THALLIUM; TIN; TRACE ELEMENT; ZINC;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; EDUCATIONAL STATUS; FAMILY HISTORY; FEMALE; HEALTH CARE SURVEY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MASS SPECTROMETRY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING HABIT; SOCIAL STATUS; WAIST HIP RATIO; AGED; BLOOD; MIDDLE AGED; NORWAY;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; TRACE ELEMENTS;

EID: 85007038743     PISSN: 0946672X     EISSN: 18783252     Source Type: Journal    
DOI: 10.1016/j.jtemb.2016.12.008     Document Type: Article

References (45)

1. [1] Mooradian, A.D., Morley, J.E., Micronutrient status in diabetes mellitus. Am. J. Clin. Nutr. 45:5 (1987), 877–895.
2. [2] Evans, J.L., Goldfine, I.D., Maddux, B.A., Grodsky, G.M., Are oxidative stress-activated signaling pathways mediators of insulin resistance and β-cell dysfunction?. Diabetes 52:1 (2003), 1–8.
3. [3] Pérez-Matute, P., Zulet, M.A., Martínez, J.A., Reactive species and diabetes: counteracting oxidative stress to improve health. Curr. Opin. Pharmacol. 9:6 (2009), 771–779.
4. [4] Hua, Y., Clark, S., Ren, J., Sreejayan, N., Molecular mechanisms of chromium in alleviating insulin resistance. J. Nutr. Biochem. 23:4 (2012), 313–319.
5. [5] Taylor, C., Zinc, the pancreas, and diabetes: insights from rodent studies and future directions. Biometals 18:4 (2005), 305–312.
6. [6] Wijesekara, N., Chimienti, F., Wheeler, M.B., Zinc, a regulator of islet function and glucose homeostasis. Diabetes Obes. Metab. 11 (2009), 202–214.
7. [7] Simcox, Judith A., McClain, Donald A., Iron and diabetes risk. Cell Metab. 17:3 (2013), 329–341.
8. [8] Hectors, T., Vanparys, C., van der Ven, K., Martens, G., Jorens, P., Van Gaal, L., Covaci, A., De Coen, W., Blust, R., Environmental pollutants and type 2 diabetes: a review of mechanisms that can disrupt beta cell function. Diabetologia 54:6 (2011), 1273–1290.
9. [9] Maull, E.A., Ahsan, H., Edwards, J., Longnecker, M.P., Navas-Acien, A., Pi, J., Silbergeld, E.K., Styblo, M., Tseng, C.H., Thayer, K.A., Loomis, D., Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ. Health Perspect. 120:12 (2012), 1658–1670.
10. [10] Thayer, K.A., Heindel, J.J., Bucher, J.R., Gallo, M.A., Role of environmental chemicals in diabetes and obesity: a National Toxicology Program workshop review. Environ. Health Perspect. 120:6 (2012), 779–789.
11. [11] Holmen, J., Midthjell, K., Krüger, Ø., Langhammer, A., Holmen, T.L., Bratberg, G.H., Vatten, L., Lund-Larsen, P.G., The Nord-Trøndelag Health Study 1995–97 (HUNT 2): objectives, contents, methods and participation. Nor. J. Epidemiol. 13:1 (2003), 19–32.
12. [12] Krokstad, S., Langhammer, A., Hveem, K., Holmen, T., Midthjell, K., Stene, T., Bratberg, G., Heggland, J., Holmen, J., Cohort profile: the HUNT study, Norway. Int. J. Epidemiol. 42:4 (2013), 968–977.
13. [13] Olsson, L., Ahlbom, A., Grill, V., Midthjell, K., Carlsson, S., High levels of education are associated with an increased risk of latent autoimmune diabetes in adults: results from the Nord-Trøndelag Health Study. Diabetes Care 34:1 (2011), 102–107.
14. [14] Sørgjerd, E.P., Skorpen, F., Kvaløy, K., Midthjell, K., Grill, V., Time dynamics of autoantibodies are coupled to phenotypes and add to the heterogeneity of autoimmune diabetes in adults: the HUNT study, Norway. Diabetologia 55:5 (2012), 1310–1318.
15. [15] Schwartz, G.G., Il'yasova, D., Ivanova, A., Urinary cadmium, impaired fasting glucose, and diabetes in the NHANES III. Diabetes Care 26:2 (2003), 468–470.
16. [16] Swaddiwudhipong, W., Limpatanachote, P., Mahasakpan, P., Krintratun, S., Punta, B., Funkhiew, T., Progress in cadmium-related health effects in persons with high environmental exposure in northwestern Thailand: a five-year follow-up. Environ. Res. 112:0 (2012), 194–198.
17. [17] Borné, Y., Fagerberg, B., Persson, M., Sallsten, G., Forsgard, N., Hedblad, B., Barregard, L., Engström, G., Cadmium exposure and incidence of diabetes mellitus—results from the Malmö diet and cancer study. PLoS One, 9(11), 2014, e112277.
18. [18] Nordberg, G., Nogawa, K., Nordberg, M., Cadmium. Nordberg, G., Fowler, B.A., Nordberg, M., (eds.) Handbook on the Toxicology of Metals, 2015, Academic Pres, Amsterdam, 667–716.
19. [19] Moon, S.S., Association of lead, mercury and cadmium with diabetes in the korean population: the Korea National Health and Nutrition Examination Survey (KNHANES) 2009–2010. Diabet. Med. 30:4 (2013), 143–148.
20. [20] Balk, E.M., Tatsioni, A., Lichtenstein, A.H., Lau, J., Pittas, A.G., Effect of chromium supplementation on glucose metabolism and lipids. Diabetes Care 30:8 (2007), 2154–2163.
21. [21] Ekmekcioglu, C., Prohaska, C., Pomazal, K., Steffan, I., Schernthaner, G., Marktl, W., Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol. Trace Elem. Res. 79:3 (2001), 205–219.
22. [22] Flores, C.R., Puga, M.P., Wrobel, K., Sevilla, M.E.G., Trace elements status in diabetes mellitus type 2: possible role of the interaction between molybdenum and copper in the progress of typical complications. Diabetes Res. Clin. Pract. 91:3 (2011), 333–341.
23. [23] Morris, B.W., MacNeil, S., Hardisty, C.A., Heller, S., Burgin, C., Gray, T.A., Chromium homeostasis in patients with type II (NIDDM) diabetes. J. Trace Elem. Med. Biol. 13:1–2 (1999), 57–61.
24. [24] Kazi, T.G., Afridi, H.I., Kazi, N., Jamali, M.K., Arain, M.B., Jalbani, N., Kandhro, G.A., Copper, chromium, manganese, iron, nickel, and zinc levels in biological samples of diabetes mellitus patients. Biol. Trace Elem. Res. 122:1 (2008), 1–18.
25. [25] Salonen, J.T., Tuomainen, T.-P., Nyyssönen, K., Lakka, H.-M., Punnonen, K., Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ 317:7160 (1998), 727–730.
26. [26] Jiang, R., Manson, J.E., Meigs, J.B., Ma, J., Rifai, N., Hu, F.B., Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 291:6 (2004), 711–717.
27. [27] Yeap, B.B., Divitini, M.L., Gunton, J.E., Olynyk, J.K., Beilby, J.P., McQuillan, B., Hung, J., Knuiman, M.W., Higher ferritin levels, but not serum iron or transferrin saturation, are associated with type 2 diabetes mellitus in adult men and women free of genetic haemochromatosis. Clin. Endocrinol. 82:4 (2015), 525–532.
28. [28] Rajpathak, S.N., Crandall, J.P., Wylie-Rosett, J., Kabat, G.C., Rohan, T.E., Hu, F.B., The role of iron in type 2 diabetes in humans. Biochim. Biophys. Acta Gen. Subj. 1790:7 (2009), 671–681.
29. [29] Swaminathan, S., Fonseca, V.A., Alam, M.G., Shah, S.V., The role of iron in diabetes and its complications. Diabetes Care 30:7 (2007), 1926–1933.
30. [30] Gabrielsen, J.S., Gao, Y., Simcox, J.A., Huang, J., Thorup, D., Jones, D., Cooksey, R.C., Gabrielsen, D., Adams, T.D., Hunt, S.C., Hopkins, P.N., Cefalu, W.T., McClain, D.A., Adipocyte iron regulates adiponectin and insulin sensitivity. J. Clin. Invest. 122:10 (2012), 3529–3540.
31. [31] Andrews, N.C., Disorders of iron metabolism. N. Engl. J. Med. 341:26 (1999), 1986–1995.
32. [32] Liu, G., Sun, L., Pan, A., Zhu, M., Li, Z., Wang, Z., Liu, X., Ye, X., Li, H., Zheng, H., Ong, C.N., Yin, H., Lin, X., Chen, Y., Nickel exposure is associated with the prevalence of type 2 diabetes in Chinese adults. Int. J. Epidemiol. 44:1 (2015), 240–248.
33. [33] Kinlaw, W.B., Levine, A.S., Morley, J.E., Silvis, S.E., McClain, C.J., Abnormal zinc metabolism in type II diabetes mellitus. Am. J. Med. 75:2 (1983), 273–277.
34. [34] Ekin, S., Mert, N., Gunduz, H., Meral, I., Serum sialic acid levels and selected mineral status in patients with type 2 diabetes mellitus. Biol. Trace Elem. Res. 94:3 (2003), 193–201.
35. [35] Abou-Seif, M.A., Youssef, A.A., Evaluation of some biochemical changes in diabetic patients. Clin. Chim. Acta 346:2 (2004), 161–170.
36. [36] Viktorínová, A., Tošerová, E., Križko, M., Ďuračková, Z., Altered metabolism of copper, zinc, and magnesium is associated with increased levels of glycated hemoglobin in patients with diabetes mellitus. Metabolism 58:10 (2009), 1477–1482.
37. [37] Basaki, M., Saeb, M., Nazifi, S., Shamsaei, H.A., Zinc, copper, iron, and chromium concentrations in young patients with type 2 diabetes mellitus. Biol. Trace Elem. Res. 148:2 (2012), 161–164.
38. [38] Shaw, J.E., Sicree, R.A., Zimmet, P.Z., Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 87:1 (2010), 4–14.
39. [39] Pidduck, H.G., Wren, P.J.J., Price Evans, D.A., Hyperzincuria of diabetes mellitus and possible genetical implications of this observation. Diabetes 19:4 (1970), 240–247.
40. [40] Yary, T., Virtanen, J.K., Ruusunen, A., Tuomainen, T.-P., Voutilainen, S., Serum zinc and risk of type 2 diabetes incidence in men: The Kuopio Ischaemic Heart Disease Risk Factor Study. J. Trace Elem. Med. Biol. 33 (2016), 120–124.
41. [41] Jansen, J., Rosenkranz, E., Overbeck, S., Warmuth, S., Mocchegiani, E., Giacconi, R., Weiskirchen, R., Karges, W., Rink, L., Disturbed zinc homeostasis in diabetic patients by in vitro and in vivo analysis of insulinomimetic activity of zinc. J. Nutr. Biochem. 23:11 (2012), 1458–1466.
42. [42] Husby, I., Sporelementer i drikkevann i Nord-Trøndelag [master's thesis]. 2014, NTNU, Trondheim, Norway.
43. [43] Navas-Acien, A., Silbergeld, E.K., Pastor-Barriuso, R., Guallar, E., Arsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 300:7 (2008), 814–822.
44. [44] Bräuner, E.V., Nordsborg, R.B., Andersen, Z.J., Tjønneland, A., Loft, S., Raaschou-Nielsen, O., Long-term exposure to low-level arsenic in drinking water and diabetes incidence: a prospective study of the diet, cancer and health cohort. Environ. Health Perspect. 122 (2014), 1059–1065.
45. [45] White, M.A., Sabbioni, E., Trace element reference values in tissues from inhabitants of the European Union. X. A study of 13 elements in blood and urine of a United Kingdom population. Sci. Total Environ. 216:3 (1998), 253–270.